Use of Integrase-Minus Lentiviral Vector for Transient Expression
Objective: Lentivirus-derived vectors are among the most promising viral vectors for gene therapy which is currently available, but their use in clinical practice is limited due to associated risk of insertional mutagenesis. Gene targeting is an ideal method for gene therapy, but it has low efficien...
Main Authors: | Hossein Azadeh, Nader Mansour Samaei, Ghasem Janbabai, Mohammad Reza Haghshenas, Hossein Khanahmad Shahreza, Touraj Farazmandfar |
---|---|
Format: | Article |
Language: | English |
Published: |
Royan Institute (ACECR), Tehran
2012-01-01
|
Series: | Cell Journal |
Subjects: | |
Online Access: | http://celljournal.org/library/upload/article/af_4233332227332425422463677633232474822732farazmandfar.pdf |
Similar Items
-
Producing Integrase Minus Lentivirus for Transient Expression of the Desired Protein and Reduced Side Effects of the Virus in Gene Therapy
by: Laleh Shariati, et al.
Published: (2015-05-01) -
Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
by: Negri Donatella RM, et al.
Published: (2012-08-01) -
Integrase deficient lentiviral vector: prospects for safe clinical applications
by: Chee-Hong Takahiro Yew, et al.
Published: (2022-08-01) -
Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza
by: Zuleika Michelini, et al.
Published: (2020-12-01) -
Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice
by: Alessandra Gallinaro, et al.
Published: (2020-06-01)